Neimeth International Pharmaceuticals Plc has reported N2.99bn from the sale of pharmaceutical products in the third quarter of 2024.
The increase in sales is largely driven by inflationary pressures and the depreciation of the Naira, which have resulted in a significant rise in the prices of pharmaceutical products across Nigeria.